Correlation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients

  • Authors:
    • Liying Guo
    • Yu Zhang
    • Wei Zhang
    • Dilimina Yilamu
  • View Affiliations

  • Published online on: March 27, 2014     https://doi.org/10.3892/etm.2014.1634
  • Pages: 1568-1572
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to investigate the association between the expression levels of estrogen receptor (ER)β and the curative effect of endocrine therapy in breast cancer patients. Cancer tissues were collected from 583 breast cancer patients between January 2000 and December 2010 and used for analysis. ERβ expression levels were determined using immunohistochemical staining. The Kaplan‑Meier method was used for survival analysis and the log‑rank test was conducted for difference analysis between survival times. In addition, Cox multivariate analysis was performed to analyze prognostic factors for breast cancer. In the immunohistochemical staining assay, a positive ERβ expression rate of <10% was defined as ERβ low expression, while >10% was defined as ERβ high expression. In patients expressing low levels of ERβ, the median tumor‑free survival time of the patients who received endocrine therapy was significantly higher compared with that of the patients who did not receive endocrine therapy. By contrast, in patients with high ERβ expression levels, there was no significant difference in the median tumor‑free survival time between the patients who received endocrine therapy and those who did not. In addition, compared with ERβ low expression patients, ERβ high expression patients had a significantly lower median tumor‑free survival time. Furthermore, ERβ expression, human epidermal growth factor receptor 2 expression, tumor size, lymph node metastasis, postoperative chemotherapy, radiotherapy and endocrine therapy were identified to be independent prognostic factors for breast cancer. Therefore, high ERβ expression in breast cancer indicates poor prognosis for endocrine therapy.
View Figures
View References

Related Articles

Journal Cover

June-2014
Volume 7 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Guo L, Zhang Y, Zhang W and Yilamu D: Correlation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients. Exp Ther Med 7: 1568-1572, 2014.
APA
Guo, L., Zhang, Y., Zhang, W., & Yilamu, D. (2014). Correlation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients. Experimental and Therapeutic Medicine, 7, 1568-1572. https://doi.org/10.3892/etm.2014.1634
MLA
Guo, L., Zhang, Y., Zhang, W., Yilamu, D."Correlation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients". Experimental and Therapeutic Medicine 7.6 (2014): 1568-1572.
Chicago
Guo, L., Zhang, Y., Zhang, W., Yilamu, D."Correlation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients". Experimental and Therapeutic Medicine 7, no. 6 (2014): 1568-1572. https://doi.org/10.3892/etm.2014.1634